OTC:VSBC | Free Cash Flow | VITASPRING BIOMEDICAL CO. LTD.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2017-01-31 to 2026-04-30
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-04-30$6,083.00
2026-01-31$124.00
2025-04-30-$787.00
2025-01-31-$1,790.00
2024-04-30-$4,023.00
2024-01-31-$2,623.00
2023-04-30-$27,940.00
2023-01-31$5,606.00
2022-04-30-$28,061.00
2022-01-31-$27,976.00
2021-04-30$358,859.00
2021-01-31-$42,858.00
2020-04-30$893.00
2020-01-31-$134.00
2019-04-30$1,516.00
2019-01-31$3,131.00
2018-04-30-$3,028.00
2018-01-31$4,820.00
2017-04-30-$2,265.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-01-31-$2,688.00
2025-01-31-$14,675.00
2024-01-31-$34,920.00
2023-01-31-$77,556.00$0.00-$77,556.00
2022-01-31-$269,631.00$72,997.00-$342,628.00-37.67%
2021-01-31-$42,130.00
2020-01-31-$105.00
2019-01-31-$34,248.00
2018-01-31$401.00
2017-01-31-$4,045.00

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.